Literature DB >> 4752061

Serum lipids in children with phenylketonuria (PKU).

P B Acosta, R B Alfin-Slater, R Koch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4752061

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


× No keyword cloud information.
  8 in total

1.  Plasma lipid concentrations in 42 treated phenylketonuric children.

Authors:  C R Galluzzo; M T Ortisi; L Castelli; C Agostoni; R Longhi
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

2.  Haemostatic variables in phenylketonuric children under dietary treatment.

Authors:  K H Schulpis; H Platokouki; E D Papakonstantinou; E Adamtziki; A Bargeliotis; S Aronis
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 3.  Lipid status and fatty acid metabolism in phenylketonuria.

Authors:  M Giovannini; G Biasucci; C Agostoni; D Luotti; E Riva
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  NORMAL FATTY ACID CONCENTRATIONS IN YOUNG CHILDREN WITH PHENYLKETONURIA (PKU).

Authors:  Stacey M Lavoie; Cary O Harding; Melanie B Gillingham
Journal:  Top Clin Nutr       Date:  2009-10-01       Impact factor: 0.508

5.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02

6.  Role of the liver in the pathogenesis of cerebral disorders in phenylketonuria.

Authors:  Y I Barashnev; V V Korneichuk; A I Klembovsky; L A Klyushina
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

7.  Problems related to diet management of maternal phenylketonuria.

Authors:  P B Acosta; S Stepnick-Gropper
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

8.  Metabolomics of dietary fatty acid restriction in patients with phenylketonuria.

Authors:  Ulrike Mütze; Skadi Beblo; Linda Kortz; Claudia Matthies; Berthold Koletzko; Mathias Bruegel; Carmen Rohde; Joachim Thiery; Wieland Kiess; Uta Ceglarek
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.